Status:

UNKNOWN

Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation

Lead Sponsor:

Sunnybrook Health Sciences Centre

Conditions:

Stroke of Basilar Artery

Optical Coherence Tomography

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Evidence regarding the role of early (\<24 hours) antithrombotics post-revascularization with either intravenous thrombolysis (IVT), endovascular thrombectomy (EVT), or a combination of both remains s...

Eligibility Criteria

Inclusion

  • \- All patients deemed candidates for endovascular thrombectomy(EVT) for basilar artery occlusion. As no robust guidelines exist for the role of EVT in patients with acute basilar artery occlusion, the decision for EVT is made by a team of stroke neurologist and neuro-interventionalist at our regional stroke center.

Exclusion

  • High-density lesion consistent with hemorrhage of any degree.
  • Significant established infarct size.
  • Contraindication to receiving post-revascularization antithrombotics for any reason (history of major hemorrhage in the past six months, hereditary or acquired bleeding diathesis, major surgery within last three months, platelets \<100 X 109 /L, coagulation factor deficiency, already on anticoagulant that would not allow administration of UFH)
  • Informed consent is not or cannot be obtained.
  • Females of childbearing potential who are known to be pregnant and/or lactating or who have positive pregnancy tests on admission.
  • Other serious, advanced, or terminal illness.
  • Patients who require hemodialysis or peritoneal dialysis.
  • Uncontrolled hypertension defined as systolic blood pressure\>185 mm Hg or diastolic blood pressure\>110mm Hg that cannot be controlled except with continuous parenteral antihypertensive medication

Key Trial Info

Start Date :

October 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 14 2021

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04121611

Start Date

October 14 2019

End Date

December 14 2021

Last Update

October 17 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sunnybrook Heath Sciences Center

Toronto, Ontario, Canada, M4N3M5